| Literature DB >> 32712376 |
Prateek Kumar Panda1, Lesa Dawman2, Pragnya Panda3, Indar Kumar Sharawat4.
Abstract
INTRODUCTION: The ongoing COVID-19 pandemic and the lockdown measures employed by the government have forced neurologists across the world to look upon telemedicine as the only feasible and practical option to continue providing health care towards children with epilepsy in home isolation. Children with epilepsy are challenging for teleconsultation as direct information from the patient is missing, regarding seizures and adverse effects, especially behavioral and psychological side effects.Entities:
Keywords: Antiepileptic drugs; COVID-19; Child neurology; Epilepsy; Teleconsultation
Mesh:
Substances:
Year: 2020 PMID: 32712376 PMCID: PMC7368411 DOI: 10.1016/j.seizure.2020.07.013
Source DB: PubMed Journal: Seizure ISSN: 1059-1311 Impact factor: 3.184
Baseline demographic and clinical variables of the sample population.
| Variable | Frequency (n = 153) | |
|---|---|---|
| Male | 95(62 %) | |
| Age (mean, SD)(in years) | 9.45 ± 3.24 | |
| Residency | Urban area | 48(31 %) |
| Rural area | 105(68 %) | |
| Socioeconomic status | Lower | 58(38 %) |
| Middle | 82(54 %) | |
| Higher | 13(8 %) | |
| Total number of telephone calls | 278 | |
| Number of telephone calls interrupted by network issues/technical glitches | 5(3.2 %) | |
| Number of telephone calls per patient (median, range) | 1 (1−5) | |
| Duration of telephone calls per patient (mean, SD) (minutes) | 7.64 ± 1.97 | |
| Caregiver satisfaction with teleconsultation | 147 (96 %) | |
Fig. 1Study flow.
The epilepsy characteristics, including neuroimaging and EEG findings of the sample population.
| Epilepsy variables | Number of participants (n = 153) | Children with uncontrolled seizure (n = 108) | Children with AED related adverse effects (n = 13) | Children with unrelated |
|---|---|---|---|---|
| Baseline seizure frequency (mean, SD) (per year) | 5.63 ± 1.78 | 4.67 ± 1.23 | 5.10 ± 1.48 | 4.13 ± 1.17 |
| Abnormal EEG | 124(81 %) | 105(97 %) | 8(61 %) | 18 (77 %) |
| Abnormal MRI brain | 79(51 %) | 71(65 %) | 3(23 %) | 13 (54 %) |
| Focal seizure | 82(53 %) | 63(58 %) | 7(53 %) | 12 (50 %) |
| Generalized seizure | 87(56 %) | 56(52 %) | 8(61 %) | 13(54 %) |
| Both generalized and focal seizure | 16(10.5 %) | 11(10 %) | 2(15 %) | 1(4 %) |
| Myoclonic seizure | 8(5.2 %) | 7(6.4 %) | 5(38 %) | 1(4 %) |
| Atonic seizure | 6(3.9 %) | 5(4.6 %) | 4(30 %) | 1(4 %) |
| Absence seizure | 3(2 %) | 1(1 %) | 0 | 0 |
| Perinatal hypoxia sequelae | 37(24 %) | 32(29 %) | 7(53 %) | 9(37 %) |
| Traumatic brain injury sequelae | 6(3.9 %) | 4(3.7 %) | 0 | 0 |
| Meningoencephalitis sequelae | 13(8.4 %) | 11(10 %) | 2(15 %) | 2(8 %) |
| Neurocysticercosis | 28(18.3 %) | 15(13.8 %) | 0 | 0 |
| Focal cortical dysplasia | 5(3.2 %) | 5(4.6 %) | 0 | 0 |
| Lennox Gastaut syndrome | 14(9.1 %) | 13(12 %) | 4(30 %) | 4 (16 %) |
| West syndrome | 2(1.3 %) | 2(1.8 %) | 0 | 0 |
| BCECTS | 17(11 %) | 7(6.4 %) | 0 | 0 |
| Early/late onset childhood occipital epilepsy | 5(3.2 %) | 3(2.7 %) | 0 | 0 |
| Primary generalized epilepsy | 16(10.4 %) | 10(9.2 %) | 0 | 0 |
| Childhood/Juvenile absence epilepsy | 3(2 %) | 1(1 %) | 0 | 0 |
| Juvenile myoclonic epilepsy | 7(4.5 %) | 5(4.6 %) | 0 | 0 |
The use of various antiepileptic drugs in the sample population.
| Variables | Number of participants (n = 153) | Children with uncontrolled seizure (n = 108) | Children with AED related adverse effects (n = 13) | Children with unrelated systemic adverse effects (n = 24) |
|---|---|---|---|---|
| Number of AEDs (mean, SD) | 1.93 ± 0.82 | 2.32 ± 0.71 | 2.86 ± 0.89 | 2.01 ± 0.87 |
| Number of patients on 1 AED | 105(68 %) | 67(62 %) | 0 | 16 (67 %) |
| Number of patients on 2 AEDs | 32(21 %) | 27(25 %) | 6(46 %) | 4(16 %) |
| Number of patients on 3 AEDs | 13(8.4 %) | 11(10 %) | 5(38 %) | 3(12 %) |
| Number of patients on 4 AEDs | 3(2 %) | 3(2.7 %) | 2(15 %) | 1(4 %) |
| Phenytoin | 37(24 %) | 29(26.8 %) | 11(84 %) | 8(33 %) |
| Valproate | 72(47 %) | 58(53.7 %) | 2(15 %) | 12(50 %) |
| Levetiracetam | 51(33 %) | 37(34.2 %) | 0 | 9(37 %) |
| Benzodiazepine | 25(16.3 %) | 16(14.8 %) | 12(92 %) | 2(8 %) |
| Oxcarbazepine | 20(13 %) | 13(12 %) | 9(69 %) | 4(16 %) |
| Topiramate | 6(4 %) | 5(4.6 %) | 1(7.6 %) | 1(4 %) |
| Zonisamide | 3(2 %) | 3(2.7 %) | 0 | 1(4 %) |
| Lamotrigine | 4(2.6 %) | 3(2.7 %) | 0 | 0 |
| Lacosamide | 2(1.3 %) | 2(1.8 %) | 0 | 0 |
Distribution of variables related to the nature of telephonic consultation and caregiver queries.
| Variable | Number of participants (n = 153) |
|---|---|
| Contacted by telephone call | 141(92 %) |
| Required follow-up telephone calls/text messages | 64(42 %) |
| Contacted by text message only | 12(7.8 %) |
| Telephone calls were supplemented by picture messages | 83(54 %) |
| Telephone calls were supplemented by video messages | 14(9.1 %) |
| Detected to have significant clinical events | 113 (74 %) |
| Advised immediate hospitalization in a nearby hospital | 5(3.2 %) |
| Merely asking for information (no active issues) | 38(25 %) |
| Grade 1 adverse effects | 8(5.2 %) |
| Adverse effects grade 2 and beyond in severity | 29(19 %) |
Fig. 2Nature of the queries raised by the caregivers.
Description of children who required modification of antiepileptic drugs or their doses.
| Variable | Number of participants (n = 153) |
|---|---|
| Required hiking up of antiepileptic drugs | 93(60 %) |
| Required addition of new antiepileptic drug due to uncontrolled seizure | 15(9.8 %) |
| Required reduction of an antiepileptic drug due to adverse effects | 9(5.8 %) |
| Required replacement of antiepileptic drug due to adverse effects | 4(2.6 %) |
| Required replacement of antiepileptic drug due to unavailability in the locality | 5(3.2 %) |
| Required replacement of prescribed commercial brand due to unavailability in the locality | 11(7.1 %) |